Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Boston Scientific's Livian CRT-D receives CE Mark

Boston Scientific : 28 December, 2007  (New Product)
Boston Scientific's cardiac resynchronization therapy defibrillator (CRT-D) has received the CE Mark approval.
The Livian CRT-D, which is a device that treats heart failure and protects patients at risk of sudden cardiac death, has been specifically designed to monitor heartbeats in heart failure patients and deliver small electrical impulses that may improve the heart's pumping ability.

The Livian CRT-D, which is available in high-energy and standard-energy
models, enables clinicians to customise therapy based on a patient's
individual needs. The implantable device uses Boston Scientific proprietary
technology - built on years of clinical research - and is designed to
improve a patient's response to cardiac resynchronization therapy. Livian
also offers clinicians technology to help manage heart failure patients with
frequent atrial arrhythmias.

'This next-generation CRT-D offers physicians in Europe and elsewhere even
more flexibility for tailoring therapy to each patient,' said Jim Tobin,
president and chief executive officer of Boston Scientific. 'It is a
testament to our ongoing commitment to providing innovative solutions for the
treatment of heart failure.'

This is the first approval of a Boston Scientific-branded cardiac rhythm
management device to treat heart failure.

The Livian CRT-D is pending approval by the US Food and Drug Administration
and is not available for sale in the USA.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo